Your session is about to expire
← Back to Search
Passive Referral to Treatment Control for Opioid Use Disorder (RIMO Trial)
RIMO Trial Summary
This trial is testing a new intervention for people who have overdosed on opioids and been given naloxone by first responders, but have not entered into MAT. The intervention is called Recovery Initiation and Management after Overdose (RIMO), and it is designed to help people connect to treatment and recovery support.
RIMO Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowRIMO Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.RIMO Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I was revived from an opioid overdose with naloxone by first responders within the last week.I am unable to understand and give consent for treatment.I have not received any treatment in the last 30 days.I am under 18 years old.
- Group 1: Recovery Initiation and Management after Overdose (RIMO)
- Group 2: Passive Referral Control
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is enrollment for this clinical research still ongoing?
"Affirmative. Clinicaltrials.gov confirms that the research project, which was first registered on April 1st 2022 is presently recruiting participants from one site with a total of 350 individuals required for completion."
What is the current participant count in this investigation?
"Correct. According to the data on clinicaltrials.gov, this medical experiment is actively recruiting participants as of July 18th 2022, having been initially posted a few months prior on April 1st. A total of 350 patients are being sought out between one site location."
What is the primary aim of this research?
"The primary measure of the clinical study, monitored over 9 months, is Time to Initiation. Secondary objectives include calculating Cost of Health Care Utilization using economic estimates and inflation rate data; gauging Mental health: Externalizing Symptoms with a 0-6 scale based on attention deficit disorders, hyperactivity, conduct issues or gambling problems; and measuring Time to Relapse in days from randomisation to next opiate/heroin use as determined by interviews and urine tests."
Share this study with friends
Copy Link
Messenger